15-70832870-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018357.4(LARP6):c.658C>A(p.Leu220Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000571 in 1,610,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018357.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LARP6 | NM_018357.4 | c.658C>A | p.Leu220Ile | missense_variant | 3/3 | ENST00000299213.10 | |
LARP6 | NM_001286679.2 | c.106C>A | p.Leu36Ile | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LARP6 | ENST00000299213.10 | c.658C>A | p.Leu220Ile | missense_variant | 3/3 | 1 | NM_018357.4 | P1 | |
LARP6 | ENST00000559316.2 | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000526 AC: 13AN: 246936Hom.: 0 AF XY: 0.0000599 AC XY: 8AN XY: 133498
GnomAD4 exome AF: 0.0000535 AC: 78AN: 1458248Hom.: 0 Cov.: 34 AF XY: 0.0000607 AC XY: 44AN XY: 725354
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.658C>A (p.L220I) alteration is located in exon 3 (coding exon 3) of the LARP6 gene. This alteration results from a C to A substitution at nucleotide position 658, causing the leucine (L) at amino acid position 220 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at